tiprankstipranks
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
Holding PMCB?
Track your performance easily

PharmaCyte Biotech (PMCB) Financial Statements

220 Followers

PharmaCyte Biotech Financial Overview

PharmaCyte Biotech's market cap is currently ―. The company's EPS TTM is $0.674; its P/E ratio is 2.59; PharmaCyte Biotech is scheduled to report earnings on March 16, 2022, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 23.42M$ 1.35M$ -1.87M$ 2.79M$ -3.18M
EBITDA$ 23.42M$ 1.35M$ -1.87M$ 2.79M$ -3.18M
Net Income Common Stockholders$ 20.59M$ -5.86M$ -5.62M$ -2.26M$ -6.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.64M$ 50.18M$ 61.21M$ 73.43M$ 74.66M
Total Assets$ 70.19M$ 59.90M$ 71.36M$ 78.88M$ 79.88M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -32.64M$ -50.18M$ -61.21M$ -73.43M$ -74.66M
Total Liabilities$ 17.15M$ 20.39M$ 22.47M$ 20.81M$ 20.40M
Stockholders Equity$ 47.71M$ 27.65M$ 31.37M$ 36.77M$ 42.73M
Cash Flow-
Free Cash Flow$ -373.30K$ -332.96K$ -177.10K$ -1.98M$ 342.96K
Operating Cash Flow$ -373.30K$ -332.96K$ -177.10K$ -1.98M$ 342.96K
Investing Cash Flow$ -7.00M-$ -5.00M--
Financing Cash Flow$ -10.17M$ -10.70M$ -7.04M$ 748.69K$ 6.28M
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

PharmaCyte Biotech Debt to Assets

PharmaCyte Biotech Cash Flow

PharmaCyte Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis